Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Isomerase
Reexamination Certificate
2000-11-17
2003-11-18
Minnifield, Nita (Department: 1645)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Isomerase
C435S023000, C435S018000, C435S212000, C435S213000, C435S007100, C435S174000, C435S004000, C435S188000, C435S252300, C435S252100, C436S512000, C514S012200, C530S810000, C530S317000, C530S330000, C530S331000, C536S023200
Reexamination Certificate
active
06649395
ABSTRACT:
BACKGROUND OF THE INVENTION
The present invention relates to a novel class of cyclophilins which contain a tyrosine residue as opposed to tryptophan or histidine in the drug binding site as well as to a method for identifying anti-parasitic compounds. More specifically, the present invention relates to a method for the identification of compounds capable of binding and/or inhibiting cyclophilins containing a tyrosine residue in lieu of tryptophan/histidine in the drug binding pocket, as well as to methods of treating parasitic infections which are not susceptible to cyclosporin A.
Cyclosporin A (CsA) is a lipophilic, 11 amino acid cyclic peptide originally isolated from the fungus
Tolypocladium inflatum
. Its immunosuppressive properties were first described in 1978 (Borel,
Pharmacol. Rev
. 41:259-371 (1990)) and it is currently the drug of choice in transplantation surgery and in the treatment of various autoimmune diseases (Kahan, “Cyclosporin: Biological activity and clinical applications,” Grune and Stratton, Orlando, Fla. (1983)).
In 1984 the receptor for CsA was identified and purified from bovine spleen, and named cyclophilin A (CypA) (Handschumacher, et al.,
Science
, 226:544-547 (1984)). CypA is an 18-kDa cytoplasmic protein (Haendler, et al.,
EMBO. J
, 6:947-950 (1987)) that is abundantly expressed in all mammalian tissues (Koletsky, et al.,
J. Immunol
. 137:1054-1059 (1986)). More recently, other cyclophilin isoforms have been described which share the highly conserved 18-kDa domain flanked by unique domains which are thought to function in organelle and membrane targeting of the protein (Gething, et al.,
Nature
355:33-45 (1992), Price, et al.,
PNAS
, 88:1903-1907 (1991), Spik, et al.,
J. Biol. Chem
. 266:10735-10738 (1991), Friedman, et al.,
Cell
66:23204-23214 (1991), and Bergsma, et al.,
J. Biol. Chem
. 266:23204-231214 (1991)). These include from humans the larger Cyp-40 (40 kDa) (Kieffer, et al.,
J. Biol. Chem
. 267:5503-5507 (1992)) and Cyp-60 (60 kDa) (Wang, et al.,
Biochem. J
. 314:313-319 (1996)) proteins, and the surface-associated natural killer (NK) cell cyclophilin (150 kDa) (Anderson,.et al.,
PNAS
, USA 90:542-546 (1993)).
Cyclophilins have also been found in several parasites including
Schistosoma mansoni
(Koletsky, et al.,
J. Immunol
, supra, Klinkert, et al.,
Mol. Biochem. Parasitol
., 75:99-111 (1995), Kiang, et al.,
Mol. Biochem. Parasitol
., 76:73-82 (1995)),
Echinococcus granulosus
(Lightowlers, et al.,
Mol. Biochem. Parasitol
., 36:287-289 (1989),
Schistosoma japonicum
(Argaet, et al.,
J. Parasitol
., 78:660-664 (1992)),
Toxoplasma gondii
(High, et al.,
J. Biol. Chem
., 269:9105-9112 (1994)),
Plasmodium falciparum
(Bell, et al.,
Biochem. Pharmacol
., 48:495-503 (1994) and Reddy et al.,
Mol. Biochem. Parasitol
., 73:111-121 (1995)),
Hymenolepis microstoma
(Roberts, et al.,
Parasitology
, 111:591-597 (1995)), and the filarial worms
Brugia malayi
(Ma, et al.,
Mol. Biochem. Parasitol
., 79:235-241 (1996) and Page, et al.,
Parasitol. Today
, 11:385-388 (1995)),
Onchocerca volvulus and Dirofilaria immitis
(Ma, et al.,
Mol. Biochem., Parasitol
. supra and Hong, et al.,
Exp. Parasitol
., in press). Multiple isoforms can exist in parasites since 2 forms have been found in
T. gondii
(High, et al.,
J. Biol. Chem
., supra) and filarial parasites (Ma, et al.,
Mol. Biochem. Parasitol, supra
, Hong, et al.,
Exp. Parasitol
, in press, supra, and Page, et al.,
Biochemistry
, 34:11545-11550 (1995)).
In addition to binding CsA, CypA was subsequently shown to possess an enzymatic activity (Fischer, et al.,
Biomed. Biochim. Acta
, 43:1101-1111 (1984)). Fischer and coworkers characterized a new enzyme from pig kidney which was capable of catalyzing the cis to trans interconversion of proline containing peptides, and hence named it peptidyl-prolyl cis-trans isomerase (PPlase). Subsequent N-terminal peptide sequencing of this enzyme revealed that it was identical to cyclophilin (Lang, et al.,
Nature
, 329:268-270 (1987)).
PPlases catalyse the cis-trans isomerisation of proline-imidic peptide bonds in oligopeptides and accelerate the refolding of several proteins in vitro (Gething, et al., Nature, supra, Lang, et al.,
Nature
, 329:268-270 (1987) and Fransson, et al.,
FEBS Lett
., 296:90-94 (1992)) and in vivo (Lodish, et al.,
J. Biol. Chem
., 266:14835-14838 (1991) and Steinmann, et al.,
J. Biol. Chem
., 266:1299-1303 (1991)). PPlases also function as protein chaperones (Freskgard, et al.,
Science
, 258:466-468 (1992) and Rinfret, et al.,
Biochemistry
, 33:1668-1673 (1994)). These properties suggest that cyclophilins may also have a critical role in parasite development.
Every cyclophilin examined to date has PPlase activity, including the CypA homologs present in
S. mansoni
(Koletsky, et al,
J. Immunol
., supra),
T. gondii
(High, et al.,
J. Biol. Chem
., supra) and
P. falciparum
(Bell, et al.,
Biochm. Pharmacol
., supra). Recombinant
B. malayi
cyclophilins were also found to possess high levels of PPlase activity (Ma, et al.,
Mol. Biochem
., Parasitol, supra and Page, et al.,
Biochemistry
, supra)
In most cases, drug binding results in inhibition of PPlase activity (Takahashi et al.,
Nature
, 337:473-475 (1989). X-ray crystallography (Pflugl, et al.,
Nature
, 361:91-94 (1993) and site-directed mutagenesis studies (Liu, et al.,
Biochemistry
30:2305-2310 (1991)) have determined that 13 specific residues comprise the drug binding site of CypA, namely, Arg-Phe-Met-Gln-Gly-Ala-Asp-Gln-Gln-Phe-Trp-Leu-His (SEQ ID NO:16). These residues are highly conserved among most cyclophilin isoforms and homologs. Liu and coworkers demonstrated that the tryptophan residue at position 121 of CypA is particularly important for drug binding. The same 13 amino acids, notably including tryptophan, are found in the CsA-sensitive cyclophilins from
E. granulosus
(Lightowlers, et al.,
Mol Biochem. Parasitol
, supra),
T. gondii
(Argaet, et al.,
J. Parasitol
., 78:660-664 (1992),
P falciparum
(Bell, et al.,
Biochem., Pharmacol
., supra, Reddy,
Mol. Biochem. Parasitol
., 73:111-121 (1995)), and the filarial Cyp-2 cyclophilins (Ma, et al.,
Mol. Biochem., Parasitol
., supra). Cyclophilins which have a residue other than tryptophan in the critical position have been reported. Human Cyp-40 (kietten, et al.,
J. Biol. Chem
., supra) and NK cell cyclophilin (Anderson, et al.,
PNAS
, supra) have histidine, and human Cyp-60 (Wang, et al.,
Biochem. J
., supra) has a tyrosine residue in this position. The Cyp-1 proteins from filarial parasites (Page, et al.,
Biochemistry
, supra, Hong, et al.,
Exp. Parasitol
., supra) and certain cyclophilins from C. elegans (Page, et al.,
Biochem. J
., 317:179-185 (1996)) also have a histidine residue in the critical position. We have determined that this amino acid difference was shown to be responsible for the lack of sensitivity of the Cyp-1 PPlase activity to inhibition with CsA
Various cDNA libraries of
B. malayi
and
O. volvulus
are currently being analyzed through tag sequencing (EST) analysis and sequences deposited in GenBank (Blaxter, et al.,
Mol. Biochem. Parasitol
., 77:77-93 (1996). Sequences related to both human Cyp-60 (‘tyrosine-containing’ cyclophilin) and a PPlase from
Schizosaccharomyces pombe
(‘histidine-containing’ cyclophilin) have been found in
B. malayi
(accession numbers W15136, AA111775) and
O. volvulus
(accession number AA294728). Based on these sequence deposits alone, there is insufficient information available to identify any of these sequences as belonging to ‘tyrosine-containing’ cyclophilins. In accordance with the present invention, it has been determined that these 3 partial sequences are related to DiCyp-3.
CsA has also been demonstrated to posses a broad spectrum anti-parasitic activity (Page, et al.,
Parasitol. Today
, supra, and Chappell, et al.,
Parasitology
, 105 Supplement, S25-S40 (1992)). The parasites
S. mansoni
(Bueding, et al.,
Agents Actions
11:380-383 (1981)),
T. gondii
(Mack, et al.,
Antimicrob Agents Chemother
, 26:
Carlow Clotilde K. S.
Hong Xiqiang
Ma Dong
Minnifield Nita
New England Biolabs Inc.
Portner Ginny Allen
Strimpel Harriet M.
Williams Gregory D.
LandOfFree
Tyrosine-containing cyclophilin and related methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyrosine-containing cyclophilin and related methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine-containing cyclophilin and related methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3180200